Masimo LHC Ltd offer for LiDCO Group Plc

November 02, 2020

London – Paul Hastings LLP, a leading global law firm, announced today that it is advising Masimo LHC Limited, a wholly-owned indirect subsidiary of Masimo Corporation (“Masimo”), on its recommended cash acquisition of the entire issued and to be issued share capital of LidCo Group plc (“LidCo”).

The acquisition was

on 2 November 2020.

Masimo is a global medical technology company that develops, manufactures, distributes, and licenses innovative patient monitoring technologies, medical devices, and a wide array of sensors. LidCo is a market leader for the provision of advanced hemodynamic monitoring products in the UK and has a growing presence in the US and many other international markets.

The Paul Hastings team was led by London partner 

 and senior associate  with support from corporate associates  and Rebecca Denton. The Paul Hastings team also included employment partner  and associate and tax partner  and associate . Masimo relationship partner and associate Regina Mendoza advised on the US securities aspects of the transaction.

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.



Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment
Becca Hatton
Katy Foster
Miranda Ward
Submission Requests
Firmwide Inquiries
Elliott Frieder

Get In Touch With Us

Contact Us